Please assess the completion status of the following clinical trial:

Trial Title: Aripiprazole in Children and Adolescents With Bipolar I Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features~Exclusion Criteria:~* Patients with certain other psychological disorders~* Patients with a co-morbid serious, uncontrolled systemic illness~* Patients with significant risk of committing suicide

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Aripiprazole 10 mg tablet
- 2 (Type: ACTIVE_COMPARATOR): Aripiprazole 30 mg tablet
- 3 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).